Medications ›mitoxantrone

mitoxantrone

RxCUI 7005 ingredient

Contraindicated with · 9

Diagnoses4

Heart Failure Pregnancy Reproduction Drug Hypersensitivity

Condition families5

Heart Diseases Reproductive Physiological Phenomena Cardiovascular Diseases Drug-Related Side Effects and Adverse Reactions Chemically-Induced Disorders

Indicated for · 37

Diagnoses12

Leukemia, Myeloid, Acute Sarcoma Leukemia, Myeloid Multiple Sclerosis Demyelinating Autoimmune Diseases, CNS Neoplasms, Connective and Soft Tissue Genital Neoplasms, Male Lymphoma Autoimmune Diseases of the Nervous System Leukemia Genital Diseases, Male Pain

Condition families25

Demyelinating Diseases Prostatic Neoplasms Prostatic Diseases Breast Neoplasms Breast Diseases Lymphatic Diseases Immunoproliferative Disorders Lymphoproliferative Disorders Urogenital Neoplasms Autoimmune Diseases Neoplasms by Histologic Type Genital Diseases Neoplasms by Site Hematologic Diseases Hemic and Lymphatic Diseases Neurologic Manifestations Neoplasms Male Urogenital Diseases Skin Diseases Nervous System Diseases Skin and Connective Tissue Diseases Urogenital Diseases Signs and Symptoms Immune System Diseases Pathological Conditions, Signs and Symptoms

MED-RT, published by the VA through NLM. Relationships attach at the ingredient level, not to a specific product or dose.

RADV audits Coding jobs Chart counter Hours & decimal time About Contact Help Terms Privacy

Innova Coding Suite extension — both tools in your browser: Add to Chrome · Add to Edge

InnovaRx — Innova Health Strategies. ICD-10-CM and the CMS-HCC risk adjustment models are published by CMS and NCHS and are in the public domain. Effective date 2026-10-22 travels in the URL, so this link shows anyone exactly what you see.